Trials / Conditions / Refractory Reflux Esophagitis
Refractory Reflux Esophagitis
4 registered clinical trials studyying Refractory Reflux Esophagitis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms NCT02986685 | Xijing Hospital of Digestive Diseases | Phase 4 |
| Completed | Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Eso NCT01669811 | AstraZeneca | Phase 3 |
| Completed | Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis NCT01321567 | Eisai Co., Ltd. | — |
| Completed | Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patien NCT00770913 | Eisai Co., Ltd. | Phase 2 / Phase 3 |